Dr Shitara on the Background of the CheckMate 649 Trial in G

Kohei Shitara, MD, discusses the background of the phase 3 CheckMate 649 study in advanced gastric cancer, GEJ cancer, and esophageal adenocarcinoma.

Related Keywords

, Kohei Shitara , National Cancer Center Hospital , Department Of Gastrointestinal Oncology , Gastrointestinal Oncology , National Cancer Center Hospital East , Clinical Oncology ,